JP2024502466A5 - - Google Patents

Info

Publication number
JP2024502466A5
JP2024502466A5 JP2023541507A JP2023541507A JP2024502466A5 JP 2024502466 A5 JP2024502466 A5 JP 2024502466A5 JP 2023541507 A JP2023541507 A JP 2023541507A JP 2023541507 A JP2023541507 A JP 2023541507A JP 2024502466 A5 JP2024502466 A5 JP 2024502466A5
Authority
JP
Japan
Prior art keywords
composition
seizure
approximately
diazepam
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023541507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024502466A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/011538 external-priority patent/WO2022150540A1/en
Publication of JP2024502466A publication Critical patent/JP2024502466A/ja
Publication of JP2024502466A5 publication Critical patent/JP2024502466A5/ja
Pending legal-status Critical Current

Links

JP2023541507A 2021-01-08 2022-01-07 抗発作治療薬の急速な送達のための方法および組成物 Pending JP2024502466A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163135291P 2021-01-08 2021-01-08
US63/135,291 2021-01-08
US202163276761P 2021-11-08 2021-11-08
US202163276760P 2021-11-08 2021-11-08
US63/276,760 2021-11-08
US63/276,761 2021-11-08
US202163284033P 2021-11-30 2021-11-30
US63/284,033 2021-11-30
PCT/US2022/011538 WO2022150540A1 (en) 2021-01-08 2022-01-07 Methods and compositions for rapid delivery of anti-seizure therapeutics

Publications (2)

Publication Number Publication Date
JP2024502466A JP2024502466A (ja) 2024-01-19
JP2024502466A5 true JP2024502466A5 (https=) 2025-01-15

Family

ID=82323232

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541507A Pending JP2024502466A (ja) 2021-01-08 2022-01-07 抗発作治療薬の急速な送達のための方法および組成物

Country Status (6)

Country Link
US (2) US20220218598A1 (https=)
EP (1) EP4274618A4 (https=)
JP (1) JP2024502466A (https=)
KR (1) KR20230144019A (https=)
AU (1) AU2022206421A1 (https=)
WO (1) WO2022150540A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024521399A (ja) 2021-06-10 2024-05-31 ニューレリス、インク． 小児患者における発作性障害を治療するための組成物および方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
US20090258865A1 (en) * 2008-03-28 2009-10-15 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
WO2012135536A1 (en) * 2011-04-01 2012-10-04 Cpex Pharmaceuticals, Inc. Nasal formulations of benzodiazepine
ES2683902T3 (es) * 2011-06-14 2018-09-28 Hale Biopharma Ventures, Llc Administración de benzodiacepina

Similar Documents

Publication Publication Date Title
JP7650929B2 (ja) 成人における焦点てんかんの処置のための合成経皮的カンナビジオール
AU2023233141B2 (en) Method of treatment with tradipitant
DE602004003172T2 (de) Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
JP6837486B2 (ja) 加齢に関連する認知障害及び神経炎症を予防及び／又は治療する方法
JP6208235B2 (ja) 多発性硬化症治療のためのビオチンの使用
RU2095060C1 (ru) Композиция, обладающая аналгетической или противовоспалительной активностью, способ аналгезии или лечения аллергических заболеваний
JP2026035701A5 (https=)
JP2007302657A (ja) 痙症の兆候および症候の緩和方法
JPS62111924A (ja) 恐慌障害の軽減剤
JP2023524039A5 (https=)
JP2021152060A (ja) アカンプロセートおよびｄ−サイクロセリンを使用する組み合わせ療法
DE60315258T2 (de) Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals
EP4520394A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
JP2024502466A5 (https=)
KR102594130B1 (ko) 편두통 치료
JP2022506019A (ja) 高用量の放出調節フペルジン製剤の使用
EP2727595B1 (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation
CN106507666A9 (zh) 1，3‑丙二磺酸或其药学上可接受的盐用于治疗肉样瘤病的用途
RU2224519C2 (ru) Антиоксидантное и стимулирующее рост нервных клеток средство
TWI642431B (zh) Ｎ－乙醯半胱胺酸用於治療突發性感覺神經性聽力損失的方法
US20190038624A1 (en) Use of abelson tyrosine kinase inhibitor in treatment of multiple system atrophy
TW202615042A (zh) 用於治療進行性纖維化間質性肺病之新穎治療組合
WO2022103352A1 (en) The use of intravenous immunoglobulin in the preparation of a drug for the treatment of cutis verticis gyrata disease
CN116036105A (zh) 一种治疗淋巴水肿的药物运用
JPS5920221A (ja) レイノ−症状の改善・治療剤